EPO and renal cell carcinoma: Since it was recently reported that RCC patients with high expression levels of Epo and EpoR have a poor prognosis (24), we selected Caki-1 and SKRC44 cells, the two cell lines in which Epo and EpoR are highly expressed, for further characterization of the mechanisms responsible for this prognosis.